{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:56:26Z","timestamp":1786982186372,"version":"build-2736575974"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T00:00:00Z","timestamp":1443398400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s12016-015-8516-5","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T03:39:13Z","timestamp":1443411553000},"page":"114-123","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":62,"title":["The Natural History and Prognosis of Primary Biliary Cirrhosis with Clinical Features of Autoimmune Hepatitis"],"prefix":"10.1007","volume":"50","author":[{"given":"Fan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qixia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoyue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaolian","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dekai","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward L.","family":"Krawitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Eric","family":"Gershwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,28]]},"reference":[{"key":"8516_CR1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/hep.22906","volume":"50","author":"KD Lindor","year":"2009","unstructured":"Lindor KD, Gershwin ME, Poupon R, Kaplan M, Bergasa NV, Heathcote EJ, American Association for Study of Liver D (2009) Primary biliary cirrhosis. Hepatology 50:291\u2013308","journal-title":"Hepatology"},{"key":"8516_CR2","doi-asserted-by":"crossref","first-page":"3525","DOI":"10.4049\/jimmunol.138.10.3525","volume":"138","author":"ME Gershwin","year":"1987","unstructured":"Gershwin ME, Mackay IR, Sturgess A, Coppel RL (1987) Identification and specificity of a cDNA encoding the 70 kd mitochondrial antigen recognized in primary biliary cirrhosis. J Immunol 138:3525\u20133531","journal-title":"J Immunol"},{"key":"8516_CR3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12016-015-8484-9","volume":"48","author":"U Beuers","year":"2015","unstructured":"Beuers U, Gershwin ME (2015) Unmet challenges in immune-mediated hepatobiliary diseases. Clin Rev Allergy Immunol 48:127\u2013131","journal-title":"Clin Rev Allergy Immunol"},{"key":"8516_CR4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s12016-015-8482-y","volume":"48","author":"T Katsumi","year":"2015","unstructured":"Katsumi T, Tomita K, Leung PS, Yang GX, Gershwin ME, Ueno Y (2015) Animal models of primary biliary cirrhosis. Clin Rev Allergy Immunol 48:142\u2013153","journal-title":"Clin Rev Allergy Immunol"},{"key":"8516_CR5","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s12016-015-8483-x","volume":"48","author":"G Rong","year":"2015","unstructured":"Rong G, Wang H, Bowlus CL, Wang C, Lu Y, Zeng Z, Qu J et al (2015) Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis. Clin Rev Allergy Immunol 48:132\u2013141","journal-title":"Clin Rev Allergy Immunol"},{"key":"8516_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2015.01.011","volume":"59","author":"YH Wang","year":"2015","unstructured":"Wang YH, Yang W, Yang JB, Jia YJ, Tang W, Gershwin ME, Ridgway WM et al (2015) Systems biologic analysis of T regulatory cells genetic pathways in murine primary biliary cirrhosis. J Autoimmun 59:26\u201337","journal-title":"J Autoimmun"},{"key":"8516_CR7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s12016-014-8419-x","volume":"48","author":"GM Hirschfield","year":"2015","unstructured":"Hirschfield GM, Siminovitch KA (2015) Genetics in PBC: what do the \"risk genes\" teach us? Clin Rev Allergy Immunol 48:176\u2013181","journal-title":"Clin Rev Allergy Immunol"},{"key":"8516_CR8","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s12016-014-8427-x","volume":"48","author":"A Floreani","year":"2015","unstructured":"Floreani A, Franceschet I, Cazzagon N, Spinazze A, Buja A, Furlan P, Baldo V et al (2015) Extrahepatic autoimmune conditions associated with primary biliary cirrhosis. Clin Rev Allergy Immunol 48:192\u2013197","journal-title":"Clin Rev Allergy Immunol"},{"key":"8516_CR9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jaut.2013.07.003","volume":"46","author":"K Hudspeth","year":"2013","unstructured":"Hudspeth K, Pontarini E, Tentorio P, Cimino M, Donadon M, Torzilli G, Lugli E et al (2013) The role of natural killer cells in autoimmune liver disease: a comprehensive review. J Autoimmun 46:55\u201365","journal-title":"J Autoimmun"},{"key":"8516_CR10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s12016-015-8471-1","volume":"48","author":"Y Sun","year":"2015","unstructured":"Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin ME (2015) The coexistence of Sjogren\u2019s syndrome and primary biliary cirrhosis: a comprehensive review. Clin Rev Allergy Immunol 48:301\u2013315","journal-title":"Clin Rev Allergy Immunol"},{"key":"8516_CR11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s12016-014-8456-5","volume":"48","author":"A Floreani","year":"2015","unstructured":"Floreani A, Franceschet I, Perini L, Cazzagon N, Gershwin ME, Bowlus CL (2015) New therapies for primary biliary cirrhosis. Clin Rev Allergy Immunol 48:263\u2013272","journal-title":"Clin Rev Allergy Immunol"},{"key":"8516_CR12","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s12016-014-8449-4","volume":"48","author":"Y Sun","year":"2015","unstructured":"Sun Y, Haapanen K, Li B, Zhang W, Van de Water J, Gershwin ME (2015) Women and primary biliary cirrhosis. Clin Rev Allergy Immunol 48:285\u2013300","journal-title":"Clin Rev Allergy Immunol"},{"key":"8516_CR13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12016-014-8446-7","volume":"48","author":"A Floreani","year":"2015","unstructured":"Floreani A, Spinazze A, Caballeria L, Reig A, Cazzagon N, Franceschet I, Buja A et al (2015) Extrahepatic malignancies in primary biliary cirrhosis: a comparative study at two European centers. Clin Rev Allergy Immunol 48:254\u2013262","journal-title":"Clin Rev Allergy Immunol"},{"key":"8516_CR14","doi-asserted-by":"crossref","unstructured":"Webb GJ, Siminovitch KA, Hirschfield GM. The immunogenetics of primary biliary cirrhosis: a comprehensive review. J Autoimmun 2015 doi: 10.1016\/j.jaut.2015.07.004.","DOI":"10.1016\/j.jaut.2015.07.004"},{"key":"8516_CR15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.02.009","volume":"51","author":"Y Yao","year":"2014","unstructured":"Yao Y, Yang W, Yang YQ, Ma HD, Lu FT, Li L, Tao YY et al (2014) Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha(\u2212\/\u2212) mice. J Autoimmun 51:99\u2013108","journal-title":"J Autoimmun"},{"key":"8516_CR16","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/hep.26682","volume":"59","author":"ME Gershwin","year":"2014","unstructured":"Gershwin ME, Krawitt EL (2014) Autoimmune hepatitis: 50 years of (slow) progress. Hepatology 59:754\u2013756","journal-title":"Hepatology"},{"key":"8516_CR17","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.27230","volume":"60","author":"A Lleo","year":"2014","unstructured":"Lleo A, Zhang W, McDonald WH, Seeley EH, Leung PS, Coppel RL, Ansari AA et al (2014) Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology 60:1314\u20131323","journal-title":"Hepatology"},{"key":"8516_CR18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00281-014-0439-3","volume":"36","author":"E Liaskou","year":"2014","unstructured":"Liaskou E, Hirschfield GM, Gershwin ME (2014) Mechanisms of tissue injury in autoimmune liver diseases. Semin Immunopathol 36:553\u2013568","journal-title":"Semin Immunopathol"},{"key":"8516_CR19","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1055\/s-0034-1383729","volume":"34","author":"L Wang","year":"2014","unstructured":"Wang L, Wang FS, Chang C, Gershwin ME (2014) Breach of tolerance: primary biliary cirrhosis. Semin Liver Dis 34:297\u2013317","journal-title":"Semin Liver Dis"},{"key":"8516_CR20","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/hep.27313","volume":"60","author":"J Zhang","year":"2014","unstructured":"Zhang J, Zhang W, Leung PS, Bowlus CL, Dhaliwal S, Coppel RL, Ansari AA et al (2014) Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 60:1708\u20131716","journal-title":"Hepatology"},{"key":"8516_CR21","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/hep.27306","volume":"61","author":"L Wang","year":"2015","unstructured":"Wang L, Sun Y, Zhang Z, Jia Y, Zou Z, Ding J, Li Y et al (2015) CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology 61:627\u2013638","journal-title":"Hepatology"},{"key":"8516_CR22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"EL Krawitt","year":"2006","unstructured":"Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354:54\u201366","journal-title":"N Engl J Med"},{"key":"8516_CR23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1002\/hep.510280203","volume":"28","author":"O Chazouilleres","year":"1998","unstructured":"Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R (1998) Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 28:296\u2013301","journal-title":"Hepatology"},{"key":"8516_CR24","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1002\/hep.510290409","volume":"29","author":"AW Lohse","year":"1999","unstructured":"Lohse AW, zum Buschenfelde KH, Franz B, Kanzler S, Gerken G, Dienes HP (1999) Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals. Hepatology 29:1078\u20131084","journal-title":"Hepatology"},{"key":"8516_CR25","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jhep.2010.09.002","volume":"54","author":"KM Boberg","year":"2011","unstructured":"Boberg KM, Chapman RW, Hirschfield GM, Lohse AW, Manns MP, Schrumpf E, International Autoimmune Hepatitis G (2011) Overlap syndromes: the International Autoimmune Hepatitis Group (IAIHG) position statement on a controversial issue. J Hepatol 54:374\u2013385","journal-title":"J Hepatol"},{"key":"8516_CR26","first-page":"55","volume":"13","author":"GM Hirschfield","year":"2011","unstructured":"Hirschfield GM, Gershwin ME (2011) Primary biliary cirrhosis: one disease with many faces. Isr Med Assoc J 13:55\u201359","journal-title":"Isr Med Assoc J"},{"key":"8516_CR27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jhep.2014.09.010","volume":"62","author":"JK Dyson","year":"2015","unstructured":"Dyson JK, Webb G, Hirschfield GM, Lohse A, Beuers U, Lindor K, Jones DE (2015) Unmet clinical need in autoimmune liver diseases. J Hepatol 62:208\u2013218","journal-title":"J Hepatol"},{"key":"8516_CR28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1053\/jhep.2002.30902","volume":"35","author":"S Joshi","year":"2002","unstructured":"Joshi S, Cauch-Dudek K, Wanless IR, Lindor KD, Jorgensen R, Batts K, Heathcote EJ (2002) Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid. Hepatol 35:409\u2013413","journal-title":"Hepatol"},{"key":"8516_CR29","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2005.10.017","volume":"44","author":"O Chazouilleres","year":"2006","unstructured":"Chazouilleres O, Wendum D, Serfaty L, Rosmorduc O, Poupon R (2006) Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. J Hepatol 44:400\u2013406","journal-title":"J Hepatol"},{"key":"8516_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jaut.2012.10.004","volume":"41","author":"Q Wang","year":"2013","unstructured":"Wang Q, Selmi C, Zhou X, Qiu D, Li Z, Miao Q, Chen X et al (2013) Epigenetic considerations and the clinical reevaluation of the overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis. J Autoimmun 41:140\u2013145","journal-title":"J Autoimmun"},{"key":"8516_CR31","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cgh.2013.09.021","volume":"12","author":"E Ozaslan","year":"2014","unstructured":"Ozaslan E, Efe C, Heurgue-Berlot A, Kav T, Masi C, Purnak T, Muratori L et al (2014) Factors associated with response to therapy and outcome of patients with primary biliary cirrhosis with features of autoimmune hepatitis. Clin Gastroenterol Hepatol 12:863\u2013869","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8516_CR32","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, Chapman RW et al (1999) International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929\u2013938","journal-title":"J Hepatol"},{"key":"8516_CR33","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1572-0241.2006.00699.x","volume":"101","author":"PC Borg ter","year":"2006","unstructured":"ter Borg PC, Schalm SW, Hansen BE, van Buuren HR, Dutch PBCSG (2006) Prognosis of ursodeoxycholic acid-treated patients with primary biliary cirrhosis. Results of a 10-yr cohort study involving 297 patients. Am J Gastroenterol 101:2044\u20132050","journal-title":"Am J Gastroenterol"},{"key":"8516_CR34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/hep.22428","volume":"48","author":"C Corpechot","year":"2008","unstructured":"Corpechot C, Abenavoli L, Rabahi N, Chretien Y, Andreani T, Johanet C, Chazouilleres O et al (2008) Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis. Hepatol 48:871\u2013877","journal-title":"Hepatol"},{"key":"8516_CR35","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2005.12.029","volume":"130","author":"A Pares","year":"2006","unstructured":"Pares A, Caballeria L, Rodes J (2006) Excellent long-term survival in patients with primary biliary cirrhosis and biochemical response to ursodeoxycholic acid. Gastroenterol 130:715\u2013720","journal-title":"Gastroenterol"},{"key":"8516_CR36","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1053\/j.gastro.2009.01.003","volume":"136","author":"EM Kuiper","year":"2009","unstructured":"Kuiper EM, Hansen BE, de Vries RA, den Ouden-Muller JW, van Ditzhuijsen TJ, Haagsma EB, Houben MH et al (2009) Improved prognosis of patients with primary biliary cirrhosis that have a biochemical response to ursodeoxycholic acid. Gastroenterol 136:1281\u20131287","journal-title":"Gastroenterol"},{"key":"8516_CR37","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/ajg.2010.216","volume":"105","author":"T Kumagi","year":"2010","unstructured":"Kumagi T, Guindi M, Fischer SE, Arenovich T, Abdalian R, Coltescu C, Heathcote EJ et al (2010) Baseline ductopenia and treatment response predict long-term histological progression in primary biliary cirrhosis. Am J Gastroenterol 105:2186\u20132194","journal-title":"Am J Gastroenterol"},{"key":"8516_CR38","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman ZD (2007) Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J Hepatol 47:598\u2013607","journal-title":"J Hepatol"},{"key":"8516_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-230X-12-1","volume":"12","author":"P Zhao","year":"2012","unstructured":"Zhao P, Han Y (2012) Low incidence of positive smooth muscle antibody and high incidence of isolated IgM elevation in Chinese patients with autoimmune hepatitis and primary biliary cirrhosis overlap syndrome: a retrospective study. BMC Gastroenterol 12:1","journal-title":"BMC Gastroenterol"},{"key":"8516_CR40","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1572-0241.2007.01136.x","volume":"102","author":"MG Silveira","year":"2007","unstructured":"Silveira MG, Talwalkar JA, Angulo P, Lindor KD (2007) Overlap of autoimmune hepatitis and primary biliary cirrhosis: long-term outcomes. Am J Gastroenterol 102:1244\u20131250","journal-title":"Am J Gastroenterol"},{"key":"8516_CR41","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1002\/hep.21472","volume":"45","author":"M Nakamura","year":"2007","unstructured":"Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y et al (2007) Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis. Hepatol 45:118\u2013127","journal-title":"Hepatol"},{"key":"8516_CR42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.jhep.2014.01.029","volume":"60","author":"PJ Trivedi","year":"2014","unstructured":"Trivedi PJ, Bruns T, Cheung A, Li KK, Kittler C, Kumagi T, Shah H et al (2014) Optimising risk stratification in primary biliary cirrhosis: AST\/platelet ratio index predicts outcome independent of ursodeoxycholic acid response. J Hepatol 60:1249\u20131258","journal-title":"J Hepatol"},{"key":"8516_CR43","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1007\/s10620-011-1661-7","volume":"56","author":"DT Zhao","year":"2011","unstructured":"Zhao DT, Liao HY, Liu YM, Zhao Y, Feng X, Yan HP (2011) Prognostic factors and survival analysis of antimitochondrial antibody-positive primary biliary cirrhosis in Chinese patients. Dig Dis Sci 56:2750\u20132757","journal-title":"Dig Dis Sci"},{"key":"8516_CR44","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0168-8278(99)80222-0","volume":"31","author":"HJ Hoogstraten van","year":"1999","unstructured":"van Hoogstraten HJ, Hansen BE, van Buuren HR, ten Kate FJ, van Berge-Henegouwen GP, Schalm SW, Dutch Multi-Centre PBC Study Group (1999) Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis. J Hepatol 31:256\u2013262","journal-title":"J Hepatol"},{"key":"8516_CR45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hep.1840100102","volume":"10","author":"ER Dickson","year":"1989","unstructured":"Dickson ER, Grambsch PM, Fleming TR, Fisher LD, Langworthy A (1989) Prognosis in primary biliary cirrhosis: model for decision making. Hepatol 10:1\u20137","journal-title":"Hepatol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8516-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8516-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8516-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T13:08:29Z","timestamp":1692018509000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8516-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,28]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["8516"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8516-5","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,28]]}}}